• I practice gastrointestinal (GI), liver, pancreatobiliary, and gynecologic pathology. I am the Director of Gastrointestinal pathology and and an Associate Director of Surgical Pathology.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection CriteriaClinical Gastroenterology and Hepatology.  17:1763-1769. 2019
    2019 Neuroendocrine proliferations in inflammatory bowel disease: differentiating neuroendocrine tumours from neuroendocrine cell micronestsHistopathology.  74:415-423. 2019
    2018 Heterogeneity of Fibrosis in Liver Biopsies of Patients with Heart Failure Undergoing Heart Transplant EvaluationAmerican Journal of Surgical Pathology.  42:1617-1624. 2018
    2018 Blimp-1 Functions as a Molecular Switch to Prevent Inflammatory Activity in Foxp3+RORγt+ Regulatory T CellsCell Reports.  25:19-28.e5. 2018
    2018 Bacterial Microbiome Dynamics in Post Pull-Through Hirschsprung-Associated Enterocolitis (HAEC): An Experimental Study Employing the Endothelin Receptor B-Null Mouse ModelFrontiers in Surgery.  5. 2018
    2017 Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant TherapyAnnals of Surgical Oncology.  24:3674-3682. 2017
    2017 Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 CasesAmerican Journal of Surgical Pathology.  41:313-325. 2017
    2016 Quantitative imaging for development of companion diagnostics to drugs targeting HGF/METJournal of Pathology: Clinical Research.  2:210-222. 2016
    2016 Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: Implications for adjuvant radiotherapyJournal of Gastrointestinal Oncology.  7:239-247. 2016
    2016 Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: A pathway distinct from poorly differentiated neuroendocrine carcinomasClinical Cancer Research.  22:1011-1017. 2016
    2016 Differences and similarities in the clinicopathological features of pancreatic neuroendocrine tumors in China and the United States: A multicenter studyMedicine.  95:e2836. 2016
    2016 The state of the art in colorectal cancer molecular biomarker testingAdvances in Anatomic Pathology.  23:92-103. 2016
    2015 An Enlarging Liver in a Young Diabetic MaleGastroenterology.  149:e8-e10. 2015
    2015 A Case of mild idiopathic adulthood ductopenia and brief review of literatureGastroenterology Report.  3:167-169. 2015
    2015 Comparison of PAX6 and PAX8 as Immunohistochemical Markers for Pancreatic Neuroendocrine TumorsEndocrine Pathology.  26:54-62. 2015
    2015 Calcifying fibrous tumor of the gastrointestinal tractArchives of Pathology and Laboratory Medicine.  139:943-947. 2015
    2015 Calcifying fibrous tumor: An unrecognized IgG4-related disease?Acta pathologica et microbiologica Scandinavica.  123:72-76. 2015
    2015 Early neoplasms of the ampulla and intrapancreatic biliary tractDiagnostic Histopathology.  21:332-339. 2015
    2015 Enterocolitis causes profound lymphoid depletion in endothelin receptor B- and endothelin 3-null mouse models of Hirschsprung-associated enterocolitisEuropean Journal of Immunology.  45:807-817. 2015
    2015 Immunohistochemistry as a surrogate for molecular diagnosis in hepatic tumoursDiagnostic Histopathology.  21:108-115. 2015
    2014 Exocrine pancreas hyperplasia without dysplasia in glucagon receptor knockout micePancreas.  43:143-145. 2014
    2014 Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of crohn's diseaseGastroenterology.  146:200-209. 2014
    2014 α-Internexin: A novel biomarker for pancreatic neuroendocrine tumor aggressivenessJournal of Clinical Endocrinology and Metabolism.  99. 2014
    2012 Adjuvant treatment of early colon cancer with micrometastases: Results of a national surveyJournal of Surgical Oncology.  106:119-122. 2012
    2012 Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liverHuman Pathology.  43:695-701. 2012
    2012 Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumorsHuman Pathology.  43:489-495. 2012
    2011 Lymph node retrieval from colorectal resection specimens for adenocarcinoma: Is it worth the extra effort to find at least 12 nodes?Colorectal Disease.  13:1377-1383. 2011

    Research Overview

  • My major area of research interest includes neuroendocrine, gastrointestinal and pancreatobiliary tumors. I mentor residents, fellows, and junior faculty in undertaking academic activities, which have resulted in presentations at various national/international pathology meetings and publications in top tier pathology journals. Apart from my own research interest, which is largely clinical and translational based, I like to participate in interdisciplinary collaborative research endeavors.
  • Teaching Overview

  • I teach residents and fellows on a daily basis. My teaching activities range from individual education during daily sign-out of cases to group sessions including slide conferences and lectures. I have been honored for my contributions to the residents education and training. In 2016, I was awarded the Golden Apple Award in appreciation for "Excellence in Teaching and Outstanding Contributions to Medical Education.
  • Education And Training

  • Doctor of Medicine, University of Mumbai 1994
  • Full Name

  • Deepti Dhall